Q2026 HCPCS Level II code: Injection, radiesse, 0.1 ml
Q2026 is the HCPCS code for “Injection, radiesse, 0.1 ml” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
Q2026Injection, radiesse, 0.1 ml
Short description: Radiesse injection
HCPCS · United States
Notes for Q2026
As CMS prints them, with any note Q2026 takes from the headings above it.
Note
- CMS processing note 0166: CR6953 RELEASED 6/4/2010, NCD 250.5 (PUB 100-03) AND CPM 32.260 (PUB 100-04).
Medicare details
The indicators CMS publishes with Q2026 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Other medical items or services
- BETOS category
- Other drugs
- Added
- Jul 1, 2010
Where Q2026 sits
- 1Q codesTemporary codes
- 2Active code Q2026Injection, radiesse, 0.1 ml
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code Q2026 mean?
Q2026 is the HCPCS code for “Injection, radiesse, 0.1 ml” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover Q2026?
CMS lists Q2026’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q2026
All Q codesQ0521Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescriptionQ1004New technology intraocular lens category 4 as defined in federal register noticeQ1005New technology intraocular lens category 5 as defined in federal register noticeQ2004Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 mlQ2009Injection, fosphenytoin, 50 mg phenytoin equivalentQ2017Injection, teniposide, 50 mgQ2028Injection, sculptra, 0.5 mgQ2034Influenza virus vaccine, split virus, for intramuscular use (agriflu)Q2035Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)Q2036Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)Q2037Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)Q2038Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)